Gender-Related Differences in the Rates of Age Associated
Thymic Atrophy by Aspinall, Richard & Andrew, Deborah
Developmental Immunology, 2001, Vol. 8(2), pp. 95-106
Reprints available directly from the publisher
Photocopying permitted by license only
(C) 2001 OPA (Overseas Publishers Association)
N.V. Published by license under
the Harwood Academic Publishers imprint,
part of The Gordon and Breach Publishing Group,
member of the Taylor and Francis Group
Gender-Related Differences in the Rates ofAge Associated
Thymic Atrophy
RICHARD ASPINALL* and DEBORAH ANDREW
Department ofImmunology Imperial College ofScience Technology and Medicine Chelsea & Westminster Hospital 369 Fulham
RoadLondon SWIO 9NH
Age associated thymic atrophy has been shown to be linked to problems with rearrangement
of the 13 chain of the T cell receptor (TCR) in male mice during the early phases of the intrath-
ymic T cell developmental pathway. In this study, thymic atrophy in female mice was found
to occur at a different rate than in male mice. At 9 months of age there was a significantly
greater number of cells in the thymus of female mice compared with male mice, with the
major difference found in the CD4/CD8
/ populations. The thymii of female mice at 9 months
of age contained double the number of these cells compared with male mice. Analysis of the
CD4+CD8
/ cells at 9 months of age demonstrated increased numbers of cells expressing
higher levels ofCD3 in females compared with males indicating that in females more of these
cells were producing successful tI3TCR pairings. In F5 transgenic mice comparison of the
CD4+C,D8+ population revealed no significant difference in their absolute numbers at
9 months of age. These results indicate that the gender differences at this time point were due
to fewer permitted divisions prior to the expression of a selectable TCR c chain within the
CD4/CD8+ populations in male compared with female mice. This gender difference was not
due to the action of testosterone and unlikely to be due to differences in the level of oestrogen.
The potential mechanisms of this difference may be related to a regulatory feedback of
peripheral T cells on the developing thymocyte populations. Such age related changes in the
numbers of cells within distinct thymic subpopulations leads to the possibility that the poten-
tial repertoire in females is greater than in males later in life.
INTRODUCTION
Age related alteration in the function of the immune
system has been recognised in many species. The
clinical presentations of such immune dysfunction are
an age-related increased susceptibility to certain
infections, an increased incidence of autoimmune dis-
ease, and certain cancers (Government Actuary’s
Department 1992, Office of National Statistics 1997,
Gardner, 1980). Laboratory investigations reveal a
reduced ability of the cells from older individuals,
compared with younger individuals, to perform in
functional in vitro assays (Flurkey et al., 1992; Bloom
and Horvath, 1994). Furthermore, analysis of certain
autoimmune diseases according to gender shows that
more women than men are affected (Whitacre et al.,
1999).
Such alterations in immune function may reflect
changes in the peripheral T cell pool. Since there are
no age-related changes either in the quantity of
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peripheral lymphocytes or in the number of CD4+ or
CD8+ T lymphocytes (Hulstaert et al., 1994; Hannet
et al., 1992) any difference must be related to the
composition of these populations. This composition is
affected by the thymic output since the rate at which
the thymus produces T cells contributing to the
peripheral T cell pool, declines with age (Mackall et
al., 1995; Mackall and Gress, 1997).
The earliest precursors of the T cell pathway in the
adult thymus are CD3-CD41CD8- (Wu et al., 1991).
This population has been subdivided on the basis of
expression of CD44 and CD25, with the most imma-
ture stage identified as CD44+CD25-. Differentiation
from this stage involves the transient expression of
CD25 and the gradual loss of CD44, during which
time the I chain of the T cell receptor (TCR) is rear-
ranged and expressed on the surface with an ct chain
equivalent (Godfrey et al., 1993; Godfrey et al.,
1994). A productive receptor at this stage allows the
cell to be positively selected and the resulting popula-
tion is CD44-CD25-CD3-CD4-CD8- and differenti-
ates to express both the CD4 and CD8 together. This
immature thymocyte is the most abundant population
in the thymus. During this phase the ct chain under-
goes rearrangement and epression and the resulting
ctl3TCR binds to an MHC molecule containing a pep-
tide on the epithelial cell (Jameson et al., 1995). The
affinity of the interaction between the TCR and the
selecting ligand determines the fate of the cell. Posi-
tive selection leads to down regulation of the RAG
genes (Brandle et al., 1992) and progression to the
next developmental stage. Failure leads to rearrange-
ment and expression of another c chain and the for-
marion of a new TCRct[3, a process repeated until the
cell is either positively selected, or dies (Petrie et al.,
1993). Positively selected cells progress to become
mature thymocytes(Alam et al., 1996). These
CD4+CD8 or CD4-CD8
/ cells are found in the
medulla, have higher levels of expression of the TCR
than their precursors, and many are cycling before
they exit to the peripheral T cell pool (Penit and Vas-
seur, 1997).
Thymic involution has been studied recently in
male mice and shown to be due to problems with rear-
rangement of the TCR-[3 chain genes affecting the
production of thymocytes (Aspinall, 1997). Differ-
ences in the rate of human thymic involution between
males and females has been described previously
(Smith and Ossa Gomez, 1981; Simpson et al., 1975)
although these descriptions have been contested
(Steinmann, 1986). Here we report that thymic atro-
phy in normal C57BL/10 mice occurs earlier in males
than in females resulting from a reduction in the
number of CD4+CD8+ thymocytes prior to positive
selection most significantly at 9 months of age.
Female F5 transgenic mice, whose transgene is a
complete TCRot[3 specific for influenza nucleoprotein
in the context of MHC Db inserted into a CD2 mini-
gene cassette (Mamalaki et al., 1993), as in male F5
transgenic mice, show no significant age related
thymic atrophy. The difference seen at 9 months of
age between normal male and female mice was not
seen between male and female F5 transgenic mice.
MATERIALS AND METHODS
Animals
Normal C57BL/10 mice were obtained from Harlan
Olac (Oxfordshire, UK) and either placed in brother
sister pairs to produce progeny, or maintained until
used. F5 transgenic animals were obtained in the first
instance from Dr D. Kioussis (National Institute of
Medical Research, Mill Hill), and colonies of aging
mice were derived by the brother sister mating of
these original animals in positive pressure isolators in
the animal house at ICSTM at Chafing Cross.
Derivation and Analysis of Tissue
Mice were killed by CO2 asphyxiation. Thymuses
were dissected cleanly out and thymocyte suspen-
sions prepared as described previously (Aspinall,
1997). For the analysis of thymocyte subpopulations
defined by their expression of CD4 and CD8, cells
were stained and incubated with; biotin-conjugated
anti-CD4 (clone KT6), streptavidin conjugated to
Quantum Red, anti-CD3-FITC (clone 29B),THYMIC ATROPHY RATES IN MALES AND FEMALES 97
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FIGURE Analysis of female murine thymocyte populations defined by the expression of CD4 and CD8 demonstrate elevated levels at 9
months of age (n=3-7 animals at each time point). After this time there is a rapid decline in all subpopulations at 12 and 18 months of age98 RICHARD ASPINALL and DEBORAH ANDREW
anti-CD8a-PE (clone 53-6.7) and anti V-ll-FITC
(clone KT 11). For the analysis of CD44 and CD25
expression on triple negative thymocytes, cells were
stained with; biotin-conjugated anti-CD4 (clone
KT6), biotin-conjugated anti-CD3 (clone KT 3),
streptavidin conjugated to R- Phycoerythrin,
anti-CD8-PE (clone 53-6.7), anti-CD44-cychrome
TM
(clone IM7), anti-CD25-FITC (clone7D4).
Control antibodies were conjugated to PE, FITC or
biotin or cy-chrome
TM Cells were fixed post-staining
with 1% paraformaldehyde in PBS, and analysed on a
Cytoron within 7 days of fixation, on a programme
acquiring 20,000 (CD4 and CD8 expression) and
50,000 cells (CD25 and CD44 expression). The abso-
lute number of cells in each subset was calculated
from the percentage of positive cells of each subset
multiplied by the total number of cells. All antibodies
were obtained from Sigma UK Ltd, Serotec UK or
Cambridge Biosciences (Pharmingen).
Statistical Analysis
Statistical analysis was carried out using the unpaired
2 tailed T test with Microsoft Excel. Differences were
considered significant for P value <0.05.
in the CD4-CD8- (P<0.05), CD4+CD8 (P<0.01) and
CD4-CD8
/ population (P<0.01). The CD4/CD8+
subpopulation shows only a marginally significant
difference (P>0.05).
After 9 months of age there is a rapid decline in all
subpopulations at 12 months and at 18 months of age
with no significant difference seen in the numbers of
cells in each subpopulation between 12 and 18
months of age (P was always greater than 0.05).
Comparison of the numbers of thymocytes in male
and female mouse thymuses
The decline in the numbers of cells within each
thymic subset with age is similar in male and female
mice such that at 6.5 months of age there is no signif-
icant difference in the total numbers within these
thymic subsets (P>0.05). However analysis revealed
that the rapid decline in total thymocyte cell number
by 9 months of age, which is a characteristic in males
was not present in females (Figure 2). At 9 months of
age, and at no other time point, there is a significant
difference in the total number of cells in the thymii of
male and female mice (P<0.01).
RESULTS
Age related changes in the female thymocyte
subpopulations
Figure 1 shows the changes in the female thymic sub-
populations with age. The most striking feature of
changes in these thymic subsets is the high cell
number in each subpopulation seen at 9 months of
age. These changes are unlikely to be due to small
sample sizes since at 6.5 months n=6 and at 9 months
n=7. Comparison of all of the thymocyte subpopula-
tions at 3 and 9 months of age shows no significant
difference (P>0.05 for the CD4-CD8-, CD4+CD8/,
CD4/CD8 and CD4-CD8
/ populations). By compar-
ison the numbers of cells present at 6.5 months was
significantly less than the number present at 3 months
187
12
I0
0 3 6 9 12 15 18
Age (months)
FIGURE 2 At 9 months of age and at no other time point there is a
significant difference(P<0.01) in the total number of cells in the
thymus of male (filled circles) and female (unfilled circles) mice
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Comparison at 9 months of age
Analysis of the number of thymocytes within the
CD4-CD8-CD3- population at 9 months of age are
shown in Figure 3(i). These results reveal similar
numbers of cells within three of the four populations
defined by their expression of CD44 and CD25. The
CD44-CD25-TN population is significantly greater in
number (P<0.05) in males where there are almost
twice the number present in females. In the
CD44/CD25-, CD44/CD25+ and CD44-CD25
/ TN
populations there is no significant difference in the
number of cells between male and female mice.
Comparison of the subsets defined by their expres-
sion of CD4 and CD8 at this age reveals no signifi-
cant difference in the numbers of CD4-CD8- cells (P
>0.05) but double the number of CD4/CD8
/ cells in
female mice compared with male mice at this age
(Figure 3ii). This was a significant increase (P<0.01).
Increased numbers of cells in the female thymus was
also noted at this time within the CD4+ and CD8
/ sin-
gle positive mature medullary thymocyte populations
compared with the male thymus.
Age changes in the female F5 transgenic mice
Analysis of the changes in number within the popula-
tions defined by their expression of CD4 and CD8
over the lifespan of the transgenic F5 female mouse is
shown in Figure 4. As with the male F5 transgenic
mouse there is none of the atrophy in the thymus seen
with aging. Comparison of total cell number and
number within the thymic subsets CD4-CD8-,
CD4/CD8+, CD4-CD8
/ at one time point with the
same population at every other time point (ie at 3
months compared with 6.5, 9, 12 and 18 months, and
at 6.5 months of age with those present at 9, 12 and 18
months, and at 9 months compared with 12 and 18
months, and at 12 months with 18 months of age)
showed no significant difference (P was always
greater than 0.05). Comparison of the numbers of
cells in the major thymic subpopulations (CD4-CD8-,
CD4/CD8+, CD4-CD8/) at 9 months of age for male
and female transgenics are shown in Table I. In con-
trast to normal male and females at 9 months of age,
there is no significant difference in numbers of
CD4/CD8
/ thymocytes.
TABLE Analysis of thymocyte numbers defined by expression of
CD4 and CD8 at 9 months of age in transgenic male and female
mice (n=5 animals at each time point)
Population Male Female P Value
CD4-CD8- 10.7 + 2.6 x 105 14.2 + 4.4 x 105 >0.05
CD4+CD8 5.7 +/- x 107 7.8 +/- 1.7 x 107 >0.05
CD4-CD8 15.4 +/- 2.2 x 106 2.4 +/- 1.3 x 107 >0.05
Comparison of CD3 expression at 9 months of age
Figure 5 shows expression of CD3 on CD4+CD8+
thymocytes on representative examples from male
and female mice at 9 months of age and compares this
with results from mice at 3 months of age. Analysis
reveals that the CD4+CD8+ populations in male and
female mice at 9 months of age show distinct differ-
ences in their fluorescent profiles. The CD4+CD8
/
population in male and female mice at 9 months of
age shows cells with bright CD3 staining but males
contain fewer cells with the dull levels of CD3
expression seen in the female at this time. This exper-
iment was repeated several times and the CD3 profile
were similar in each sex showing the reproducibility
of this gender difference (data not shown). The
reduced dull CD3 population in the males at 9 months
of age was linked to age and not sex as shown by the
fluorescence profile in Figure 6. Analysis of the
CD4/CD8+ population for expression of CD3 in nor-
mal male and female mice at 3 months of age is
shown in this figure. The results reveal that anti-CD3
antibodies stain the gated CD4/CD8
/ population pro-
ducing a profile similar for both sexes at this age.
DISCUSSION
This study clearly demonstrates gender-related differ-
ence in the rate at which the thymus atrophies with
age. Thymic decline appears to be similar initially in
both male and female mice but around 9 months of
age there was a significantly higher number of cells in
the female compared with the male thymus. It is
unlikely that this could be accounted for by a single
event in the maintenance of the animals since at this100 RICHARD ASPINALL and DEBORAH ANDREW
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FIGURE 3 Analysis of thymocyte numbers at 9 months of age shows (i) similar numbers within all 4 TN populations defined by their
expression ofCD44 and CD25 and (ii) a significant increase (P<0.01) in the number ofCD4/CD8 cells in female (unfilled bars) mice when
compared to males (filled bars). Increased numbers ofCD4 and CD8 cells were noted in the female thymus at this time point (n=4)
time point animals were analysed in separate batches
at time intervals which were months apart.
Previous work considered that the decline in the
cellularity within the male thymus follows the princi-
ples of a single hit model (Aspinall, 1997). In this
model a problem in the rearrangement of the TCR[
chain leads to a decline in the numbers of
+ + CD44 CD25 TN and their progeny theTHYMIC ATROPHY RATES IN MALES AND FEMALES 101
CD44-CD25+TN and CD44-CD25-TN populations
but no change in the numbers of their precursors the
CD44/CD25-TN population. The data comparing the
numbers of cells at different stages in the T cell differ-
entiation pathway prior to the expression of CD4,
CD8 and CD3 would support the hypothesis that in
females, as in males, there is a problem with the rear-
rangement of the TCR[3 chain. This hypothesis is sup-
ported by results from F5 transgenic mice which do
not show age-associated thymic atrophy. These mice
carry a complete czI3TCR as a transgene (Mamalaki et
al., 1993) and so have no requirement for rearrange-
ment to produce a selectable TCR.
The results showing no significant difference
between males and females in the numbers of
CD44+CD25-TN, CD44/CD25/TN and
CD44-CD25
/ TN populations at 9 months of age
demonstrates that the factors affecting the production
or survival of these cells are the same in both sexes.
There were significant differences in the
CD44-CD25- TN population with almost double the
number of these cells in males than females. The
progeny of these cells are the CD4+CD8
/ population
and at 9 months of age there were significant differ-
ences in the number of these in females compared
with males. These increased numbers in females pro-
duced from precursors whose numbers were less than
the numbers of the same phenotypic population in
males, indicates that there must be more permitted
divisions within the CD4/CD8+ population in
females compared with males.
A critical decision point within the CD4/CD8+pop
ulation is positive selection on the basis of the
[3TCR pairing achieved (Jameson et al., 1995). This
is critical because it impacts upon the diversity of the
potential repertoire to be generated. Because of this it
was important to determine whether the gender differ-
ences in CD4+CD8+ cell numbers represent differ-
ences prior to positive selection or after positive
selection. The data from normal animals showing
more CD4/CD8
/ cells with higher expression ofCD3
at 9 months of age in females compared with males
are not conclusive on this issue. However the results
from the transgenic F5 mice are conclusive and indi-
cate that the differences seen in the normal mice must
be due to greater division before positive selection.
Intrathymic T cell differentiation in the F5 mice is
normal, proceeding through the same developmental
stages as non-transgenic mice. F5 mice show the
same changes in the levels of TCR expressed at dif-
ferent stages of thymocyte development, with
increased expression correlating with maturity of the
thymic subpopulation. In addition the thymocytes in
F5 mice show positive selection in C57BL/10 mice
and negative selection in animals expressing Class II
MHC IE molecules and the endogenous Mtv ligand
(Mamalaki et al., 1993).
The F5 data indicates that the difference seen in
normal animals is not due to clonal expansion after
production of a functional ct[3TCR, since this would
result in an increased number of CD4+CD8
/ cells in
F5 females compared with males, a result which was
not observed. The differences must be due to gender
related differences in the number of permitted divi-
sions prior to positive selection at 9 months of age.
Any proposal that gender differences in the
CD4+CD8/population represent differences in the
transit time through these subpopulations would also
be difficult to sustain in view of the result from the
transgenic mice.
The rate of thymic atrophy between males and
females appears to be similar between the ages of 3
and 6 months but differences arise at 9 months of age
when thymic size is greater in females than in males.
This movement of the female thymus away from the
trend of decline seen in the male may be the result of
some stimulatory effect in the female or some inhibi-
tory effect in the male. Explanations of these gender
differences include both hormonal causes and
immune related mechanisms. For a hormonal related
mechanism, testosterone would seem to provide a
solution to the difference since it is known to induce
apoptosis in CD4+CD8
/ cells (Olsen et al., 1998).
Furthermore reduction in testosterone levels by
orchidectomy leads to a reversal of age related thymic
atrophy and an increase in thymic subpopulations,
which could be inhibited by testosterone in a dose
dependant fashion (Greenstein et al., 1986). But the
lack of any significant difference in the numbers of
cells between male and female F5 transgenic mice
makes this hypothesis difficult to sustain. The hypoth-102 RICHARD ASPINALL and DEBORAH ANDREW
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FIGURE 4 Age associated thymic atrophy was not observed in female F5 transgenic mice. Comparison of the numbers within the population
defined by their expression ofCD4 and CD8 in female mice reveals no difference with age (n=3-6 animals at each time point)
esis would only be tenable if the F5 were not suscepti-
ble to the effects of testosterone. Experiments carded
out to test this hypothesis revealed that cultures of
fetal F5 thymuses in the presence of different concen-
trations of testosterone demonstrated similar reduc-
tions in thymic subpopulations as seen with fetal
thymuses from normal animals (data not shown).
Alternatively the differences may be due to altera-
tions in the levels of oestrogen with age, since oestro-
gen is also known to inhibit thymocyte developmentTHYMIC ATROPHY RATES IN MALES AND FEMALES 103
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FIGURE 5 A representative experiment demonstrating low to intermediate expression of CD3 on CD4+CD8 thymocytes is markedly
reduced in males but not in females by 9 months of age
(Rijhsinghani et al., 1997). The idea that a rapid age
related reduction in the levels of oestrogen produced
less inhibition allowing more permitted divisions at 9
months of age in female CD4/CD8+ cells rather than
males seems unlikely following previous studies
showing that oophorectomy does not enhance T cell
development (Rijhsinghani et al., 1996).
A potential mechanism to account for the gender
related differences relates to a regulatory feedback
pathway in the thymus. Previous reports suggested
that there was negative feedback control over the total
production of lymphocytes by the thymus acting at
the CD4+CD8
/ stage of the pathway (Mehr et al.,
1996). The mechanism involves the effect of mature
CD4+ T cells acting on these stages through the
cytokines they produce (Mehr et al., 1997). Gender
differences have been shown to affect the cytokine
production by T cells following antigen challenge104 RICHARD ASPINALL and DEBORAH ANDREW
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FIGURE 6 A representative experiment demonstrating similar CD3 expression on CD4+CD8 thymocytes in males and females at 3 months
of age
thus having an influence on the TH1/TH2 balance
depending on the hormone and dose (Piccinni et al.,
1995; Dalai et al., 1997; Whitacre et al., 1999). Since
recirculation from the periphery back to the thymus is
restricted to activated T cells (Surh et al., 1993; Agus
et al., 1991), the cells entering the thymus at 9 months
of age will be secreting cytokines which in turn may
alter the maturation kinetics of the CD4+CD8
/ popu-
lation. However this effect is not permanent since in
normal mice the differences do not exist after 9
months of age. An alternative explanation is that there
are differences in the numbers of dendritic cells enter-
ing the thymus in males and female mice at this age,
since there may be a correlation between the numberTHYMIC ATROPHY RATES IN MALES AND FEMALES 105
of dendritic cells and the number of CD4+CD8+cells
(Anderson et al., 1998). However why such an effect
is transitory is difficult to envisage.
The conclusions then from this work is that age
associated thymic atrophy in females is due to a prob-
lem with rearrangement of the TCR chain. This is
shown by female F5 transgenic mice failing to
undergo age-associated thymic atrophy, which is
identical to that seen with males. Furthermore in nor-
mal non-transgenic male and female mice it is clear
that the lowest point of thymic atrophy is reached by
12 months of age after which time there appear to be
no sex related differences in thymic size. Before
this age however, the differences seen in the thymus
between normal male and female animals would sug-
gest that there is an additional cause of atrophy in the
male that permits fewer divisions between the pheno-
type stages of CD44-CD25- TN and CD4+CD8/. This
would seem to show the greatest difference at 9
months of age. At present the most likely explanation
for this is a negative feedback due to mature CD4+ T
cells affecting this stage of the pathway.
The implications of this are that males of this age
will show fewer TCRc3 pairings that in tum may
restrict the potential repertoire in males later in life.
This also implies that the female mice should have a
larger potential repertoire later in life than males.
Acknowledgements
We are grateful to Professor Frances Gotch and Dr Nes-
rina lmami for their comments on the manuscript and for
fruitful discussions on this work. The work was sup-
ported by the Wellcome Trust (Grant Number 051541).
References
(1992). The Government Actuary’s Department.
(1997). Office of National Statistics. (Abstract).
Agus, D.B., Surh, C.D., and Sprent, J. (1991). Reentry of T cells to
the adult thymus is restricted to activated T cells. J. Exp. Med.
173, 1039-1046.
Alam, S.M., Travers, P.J., Wung, J.L., Nasholds, W., Redpath, S.,
Jameson, S.C., and Gascoigne, N.R. (1996). T-cell-receptor
affinity and thymocyte positive selection [see comments].
Nature 381, 616-620.
Anderson, G., Partington, K.M., and Jenkinson, E.J. (1998). Differ-
ential effects of peptide diversity and stromal cell type in posi-
tive and negative selection in the thymus. J. Immunol. 161,
6599-6603.
Aspinall, R. (1997). Age-associated thymic atrophy in the mouse is
due to a deficiency affecting rearrangement of the TCR during
intrathymic T cell development. J. Immunol. 158, 3037-3045.
Bloom, E.T. and Horvath, J.A. (1994). Cellular and molecular
mechanisms of the IL-12-induced increase in allospecific
murine cytolytic T cell activity. Implications for the
age-related decline in CTL. J. Immunol. 152, 4242-4254.
Brandle, D., Muller, C., Rulicke, T., Hengartner, H., and Pircher, H.
(1992). Engagement of the T-cell receptor during positive
selection in the thymus down-regulates RAG-1 expression.
Proc. Natl. Acad. Sci. U.S.A. 89, 9529-9533.
Dalai, M., Kim, S., and Voskuhl, R.R. (1997). Testosterone therapy
ameliorates experimental autoimmune encephalomyelitis and
induces a T helper 2 bias in the autoantigen-specific T lym-
phocyte response. J. Immunol. 159, 3-6.
Flurkey, K., Miller, R.A., and Harrison, D.E. (1992). Cellular deter-
minants of age-related decrements in the T-cell mitogen
response ofB6CBAF1 mice. J. Gerontol. 47, Bl15-20.
Gardner, I.D. (1980). The effect of aging on susceptibility to infec-
tion. Rev. Infect. Dis. 2, 801-810.
Godfrey, D.I., Kennedy, J., Suda, T., and Zlotnik, A. (1993). A
developmental pathway involving four phenotypically and
functionally distinct subsets of CD3-CD4-CD8- triple-nega-
tive adult mouse thymocytes defined by CD44 and CD25
expression. J. Immunol. 150, 4244-4252.
Godfrey, D.I., Kennedy, J., Mombaerts, P., Tonegawa, S., and Zlot-
nik, A. (1994). Onset of TCR-beta gene rearrangement and
role of TCR-beta expression during CD3-CD4-CD8- thymo-
cyte differentiation. J. Immunol. 152, 4783-4792.
Greenstein, B.D., Fitzpatrick, ET., Adcock, I.M., Kendall, M.D.,
and Wheeler, M.J. (1986). Reappearance of the thymus in old
rats after orchidectomy: inhibition of regeneration by testo-
sterone. J. Endocrinol. 110, 417-422.
Hannet, I., Erkeller Yuksel, E, Lydyard, P., Deneys, V., and DeBru-
yere, M. (1992). Developmental and maturational changes in
human blood lymphocyte subpopulations [see comments].
Immunol. Today 13, 215,218.
Hulstaert, E, Hannet, I., Deneys, V., Munhyeshuli, V., Reichert, T.,
De Bruyere, M., and Strauss, K. (1994). Age-related changes
in human blood lymphocyte subpopulations. II. Varying kinet-
ics of percentage and absolute count measurements
Age-related changes in human blood lymphocyte subpopula-
tions. II. Varying kinetics of percentage and absolute count
measurements. Clin. Immunol. Immunopathol. 70, 152-158.
Jameson, S.C., Hogquist, K.A., and Bevan, M.J. (1995). Positive
selection of thymocytes. Annu. Rev. Immunol. 13, 93-126.
Mackall, C.L., Fleisher, T.A., Brown, M.R., Andrich, M.P., Chen,
C.C., Feuerstein, I.M., Horowitz, M.E., Magrath, I.T., Shad,
A.T., Steinberg, S.M., and et al (1995). Age, thymopoiesis,
and CD4+ T-lymphocyte regeneration after intensive chemo-
therapy [see comments]. N. Engl. J. Med. 332, 143-149.
Mackall, C.L. and Gress, R.E. (1997). Thymic aging and T-cell
regeneration. Immunol. Rev. 160, 91-102.
Mamalaki, C., Elliott, J., Norton, T., Yannoutsos, N., Townsend,
A.R., Chandler, P., Simpson, E., and Kioussis, D. (1993). Pos-
itive and negative selection in transgenic mice expressing a
T-cell receptor specific for influenza nucleoprotein and endog-
enous superantigen. Dev. Immunol. 3, 159-174.
Mehr, R., Perelson, A.S., Fridkis Hareli, M., and Globerson, A.
(1996). Feedback regulation ofT cell development: manifesta-
tions in aging. Mech. Ageing Dev. 91, 195-210.
Mehr, R., Perelson, A.S., Fridkis Hareli, M., and Globerson, A.
(1997). Regulatory feedback pathways in the thymus. Immu-
nol. Today 18, 581-585.106 RICHARD ASPINALL and DEBORAH ANDREW
Olsen, N.J., Viselli, S.M., Fan, J., and Kovacs, W.J. (1998). Andro-
gens accelerate thymocyte apoptosis. Endocrinology 139,
748-752.
Penit, C. and Vasseur, F. (1997). Expansion of mature thymocyte
subsets before emigration to the periphery. J. Immunol. 159,
4848-4856.
Petrie, H.T., Livak, F., Schatz, D.G., Strasser, A., Crispe, I.N., and
Shortman, K. (1993). Multiple rearrangements in T cell recep-
tor alpha chain genes maximize the production of useful thy-
mocytes. J. Exp. Med. 178, 615-622.
Piccinni, M.P., Giudizi, M.G., Biagiotti, R., Beloni, L., Giannarini,
L., Sampognaro, S., Parronchi, P., Manetti, R., Annunziato, F.,
Livi, C., and et al (1995). Progesterone favors the develop-
ment of human T helper cells producing Th2-type cytokines
and promotes both IL-4 production and membrane CD30
expression in established Thl cell clones. J. Immunol. 155,
128-133.
Rijhsinghani, A.G., Thompson, K., Bhatia, S.K., and Waldschmidt,
T.J. (1996). Estrogen blocks early T cell development in the
thymus. Am. J. Reprod. Immunol. 311, 269-277.
Rijhsinghani, A., Bhatia, S.K., Kantamneni, L., Schlueter, A., and
Waldschmidt, T.J. (1997). Estrogen inhibits fetal thymocyte
development in vitro. Am. J. Reprod. Immunol. 37, 384-390.
Simpson, J.G., Gray, E.S., and Beck, J.S. (1975). Age involution in
the normal human adult thymus. Clin. Exp. Immunol. 19,
261-265.
Smith, S.M. and Ossa Gomez, L.J. (1981). A quantitative histologic
comparison of the thymus in 100 healthy and diseased adults.
Am. J. Clin. Pathol. 711, 657-665.
Steinmann, G.G. (1986). Changes in the human thymus during
aging. Curr. Top. Pathol. 75, 43-88.
Surh, C.D., Sprent, J., and Webb, S.R. (1993). Exclusion of circu-
lating T cells from the thymus does not apply in the neonatal
period. J. Exp. Med. 177, 379-385.
Whitacre, C.A., Reingold, S.C., O’Looney, P.A., and Task Force
(1999). A Gender Gap in Autoimmunity. Scince 283, 1277-
1278.
Wu, L., Scollay, R., Egerton, M., Pearse, M., Spangrude, G.J., and
Shortman, K. (1991). CD4 expressed on earliest T-lineage pre-
cursor cells in the adult murine thymus. Nature 349, 71-74.